15
Participants
Start Date
October 5, 2023
Primary Completion Date
January 13, 2025
Study Completion Date
October 31, 2025
Alpelisib
Patients will receive standard of care alpelisib
FreeStyle Libre 2 Continuous Glucose Monitor
All patients will wear Abbott FreeStyle Libre 2 system to obtain CGM data (glucoses measured every minute for 14 days). CGM monitors will be placed at least 10 days prior to starting alpelisib and continue CGM for at least 3 months while taking alpelisib.
HealthPartners Cancer Research Center, Saint Louis Park
HealthPartners Institute
OTHER